Latest News in Cancer
Stay updated with the most recent articles and resources.
Main Topics
Toripalimab-tpzi is approved by the FDA for nasopharyngeal carcinoma
In October 2023, the FDA approved toripalimab-tpzi (LOQTORZ, Coherus BioSciences, Inc.) with cisplatin and gemcitabine as the first-line treatment for people with locally advanced nasopharyngeal...
Stem Cell Therapy for Diabetes: A Promising Treatment Approach
March 2024: Stem cell therapy has emerged as a promising treatment option for diabetes mellitus, potentially addressing the obstacles that patients encounter. Research in this...
Revolutionizing Multiple Myeloma Treatment through CAR T-Cell Therapy in China
Feb 2024: China’s pioneering efforts in creating breakthrough cancer therapeutics have gained traction with the introduction of chimeric antigen receptor (CAR)-engineered T-cell (CAR T) therapy...
Mesenchymal stem cells (MSC) and platelet-rich plasma (PRP) therapy in the treatment of knee osteoarthritis
Feb 2024: Mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) therapy have shown potential in treating knee osteoarthritis (KOA) in China. A meta-analysis of randomized...
Tumor-Infiltrating Lymphocyte (TIL) Therapy in China
Feb 2024: Tumor-infiltrating lymphocyte (TIL) therapy treatment is a potential method that utilizes the body’s immune system to fight solid tumors. This therapeutic area in...
The Life-Changing Treatment for Blood Cancer Finally Exposed!
Blood cancer is a type of cancer that affects both the blood and bone marrow. It is the fifth most common type of cancer in...
Clinical Trials Of CAR T-Cell Therapy In China Has Shown Remarkable Success
CAR T-Cell therapy trials in China 2024 has been a game-changer for CAR T-Cell therapy in China! Witness remarkable success stories from clinical trials, explore...
A Closer Look At Recent Cancer Clinical Trials In China And New Cancer Drug Approved
This article closely examines cancer clinical trials in China in the past few years, focusing on major findings and areas of progress. It also discusses...
NMPA Approves FUCASO: Multiple Myeloma Treatment In China
FUCASO treatment in China The overall response rate of this revolutionary cancer therapy named FUCASO is 96%. The NMPA’s approval marks a turning point in...
Breast Cancer Treatment Costs in India in 2025
Cost of breast cancer treatment in India in 2025 Breast cancer accounts for 31% of all cancers diagnosed in Indian women, making it...
How is PET CT scanning changing the lives of cancer patients worldwide?
A PET scan is a ray of hope in the fight against cancer. If your doctor suspects a case of cancer, they might use this...
Free Cancer Treatment In China Without Breaking The Bank: A Guide For Those Who Need It Most
Free cancer treatment in China is providing hope and healing to people in need. So, if you are unable to opt for cancer treatment because...
Need help? Our team is ready to assist you.
We wish a speedy recovery for your loved ones.